the 62% efficacy rate was for symptomatic cases, which makes those numbers comparable to the Biontech/Pfizer one. I think it was around 50% effective in stoppin

the 62% efficacy rate was for symptomatic cases, which makes those numbers comparable to the Biontech/Pfizer one. I think it was around 50% effective in stopping asymptomatic cases, which is also pretty good. But that main number comes from symptomatic cases